000 01295 a2200373 4500
005 20250515004532.0
264 0 _c20051222
008 200512s 0 0 eng d
022 _a0008-5472
024 7 _a10.1158/0008-5472.CAN-05-1241
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJudkins, Thaddeus
245 0 0 _aApplication of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutations.
_h[electronic resource]
260 _bCancer research
_cNov 2005
300 _a10096-103 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAlleles
650 0 4 _aBreast Neoplasms
_xgenetics
650 0 4 _aGenes, BRCA1
650 0 4 _aHaplotypes
650 0 4 _aHumans
650 0 4 _aMutation
650 0 4 _aPolymorphism, Single Nucleotide
700 1 _aHendrickson, Brant C
700 1 _aDeffenbaugh, Amie M
700 1 _aEliason, Kristilyn
700 1 _aLeclair, BenoƮt
700 1 _aNorton, Michael J
700 1 _aWard, Brian E
700 1 _aPruss, Dmitri
700 1 _aScholl, Thomas
773 0 _tCancer research
_gvol. 65
_gno. 21
_gp. 10096-103
856 4 0 _uhttps://doi.org/10.1158/0008-5472.CAN-05-1241
_zAvailable from publisher's website
999 _c15892520
_d15892520